Posters

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30

Sunday, September 28

4:45 PM - 6:00 PM PT

2403 - Radiomic Analysis for Prediction of Progression Free Survival and Early Polymetastatic Progression in Lung Oligometastases Patients on SABR-5 Trial
Speaker: Kunkyab, Tenzin, PhD - The Mount Sinai Hospital, New York, NY
4:45 PM - 6:00 PM PT

2404 - Assessment of the Appropriateness of the Selection for Radiotherapy Intensity from a Quality of Life (EORTC QLQ-C30) Perspective in Older Cancer Patients
Speaker: Kuribayashi, Shigehiko, MD, PhD - Tokyo Womens Medical University, Tokyo 162-8666
4:45 PM - 6:00 PM PT

2405 - Optimizing Chemoradiotherapy for Small Cell Lung Cancer in the Immunotherapy Era
Speaker: Lambert, Travis, MD - Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
4:45 PM - 6:00 PM PT

2406 - Do Patients with Head and Neck Cancer Feel Anxious about Mask Use during Radiotherapy ? Importance of Medical Support and Coping Strategies
Speaker: Laraichi, Rachida - National Institute of Oncology, Budapest, Rabat
4:45 PM - 6:00 PM PT

2407 - Single-Fraction Lung SBRT for Primary and Metastatic Lung Tumors: Ten-Year Experience
Speaker: Larrea, Luis, MD, PhD - Hospital Vithas Valencia Consuelo, Valencia, Valencia
4:45 PM - 6:00 PM PT

2408 - Retrospective Study of the Efficacy and Safety of Lung Malignancy Radiation In-Field of Prior Ipsilateral Breast Radiation
Speaker: Lawlor, Mary-Kate, MD - Yale New Haven Health, New Haven, CT
4:45 PM - 6:00 PM PT

2409 - Clinical Factors Associated with Urinary Morbidity in Men Undergoing Combination Prostate Radiation Therapy
Speaker: Lee, Benjamin, MD - Urology of Greater Atlanta, Stockbridge, GA
4:45 PM - 6:00 PM PT

2410 - Genomic Predictors of Brain Metastases in Non-Small Cell Lung Cancer: Implications for Early Detection and Targeted Surveillance
Speaker: Lee, Victor, MD, BS - Yale New Haven Hospital, Middletown, CT
4:45 PM - 6:00 PM PT

2411 - Lung V5 and Post-Radiation Lymphopenia as Predictors of Symptomatic Radiation Pneumonitis in Real-World Lung Cancer Patients in China: A Retrospective Analysis
Speaker: Lei, Qianqian, MD - Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing, Chongqing
4:45 PM - 6:00 PM PT

2412 - Screening of the Population Benefiting from Postoperative Radiotherapy in Resectable Stage III-N2 NSCLC Patients Receiving Neoadjuvant Chemoimmunotherapy
Speaker: Li, Min - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan
4:45 PM - 6:00 PM PT

2413 - Identification of Radioresistance Biomarkers Using Surface-Enhanced Raman Scattering (SERS) Molecular Diagnosis and Multi-Omics in NSCLC Cells
Speaker: Li, Nan, MD - Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing, China, Chongqing
4:45 PM - 6:00 PM PT

2414 - Induction Chemotherapy Administration Increases the Risk of Radiation Pneumonitis in Unresectable Stage III NSCLC Patients Undergoing Concurrent Chemoradiotherapy with Immunotherapy
Speaker: Li, Pengwei - Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong